 |
(S)-4,5-dihydro-2[2-hydroxy-3-(3,6,9-trioxadecyloxy)phenyl]-4-methyl-4-thiaxolecarboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic iron overload in patients with transfusion-dependent anemias |
| USA Market Approval | USA |
| USA Designation Date | 2009-02-04 00:00:00 |
| Sponsor | Ferrokin BioSciences, Inc.;2729 Debbie Court;San Carlos, California, 94070 |
